Skip to main content
OpenTrials

Clinical trial condition

Disorders of Excessive Somnolence

Explore clinical trials studying Disorders of Excessive Somnolence. Study availability and eligibility vary by location and protocol.

154 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Disorders of Excessive Somnolence trial results

Completed

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia

NCT05458128

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Excessive Daytime Sleepiness, +8 more
Locations
  • Cedars-Sinai Medical Towers Los Angeles, California, United States
  • Sleep Medicine Specialists of California San Ramon, California, United States
  • Meris Clinical Research Brandon, Florida, United States
  • St. Francis Medical Institute Clearwater, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

NCT05113745

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Boulder, Colorado, United States
  • Clinical Research Site Colorado Springs, Colorado, United States
  • Clinical Research Site Brandon, Florida, United States
View all 25 locations
View Trial Details
Completed

An Open Label Study of FT218 in Subjects With Narcolepsy

NCT04451668

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +12 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Redwood City, California, United States
  • SDS Clinical Trials Santa Ana, California, United States
  • Alpine Clinical Research Center Boulder, Colorado, United States
View all 29 locations
View Trial Details
Completed

Prevalence of Sleep Disturbances in Elderly People Hospitalized in Medicine, Psychiatry and Rehabilitation Departments: TOPASE Prospective Study, RIPH 3

NCT06659575

Conditions
D012893, Disorders of Excessive Somnolence, Dyssomnias, +9 more
Locations
  • Angers_CHU Angers, France
  • Etablissement de santé Baugeois-Vallée Baugé-en-Anjou, France
  • CH de la corniche angevine Chalonnes-sur-Loire, France
  • Cholet_Ch Cholet, France
View Trial Details
Completed

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)

NCT06103825

Conditions
Apnea, Disorders of Excessive Somnolence, Dyssomnias, +9 more
Locations
  • Shanghai Sixth People's Hospital Shanghai, Shanghai Municipality, China
  • Beijing TianTan Hospital Capital Medical University Beijing, China
  • China-Japan friendship Hospital Beijing, China
  • Peking University Sixth Hospital Beijing, China
View all 26 locations
View Trial Details

Related conditions